Results 61 to 70 of about 3,458 (212)

Multiple cyclophilins involved in different cellular pathways mediate HCV replication

open access: yes, 2010
Three cyclophilin inhibitors (DEBIO-025, SCY635, and NIM811) are currently in clinical trials for hepatitis C therapy. The mechanism of action of these, however, is not completely understood.
Baryza, Jeremy   +18 more
core   +1 more source

Evaluation of NV556, a Novel Cyclophilin Inhibitor, as a Potential Antifibrotic Compound for Liver Fibrosis

open access: yesCells, 2019
Hepatic fibrosis can result as a pathological response to nonalcoholic steatohepatitis (NASH). Cirrhosis, the late stage of fibrosis, has been linked to poor survival and an increased risk of developing hepatocellular carcinoma, with limited treatment ...
Sonia Simón Serrano   +12 more
doaj   +1 more source

Comparative analysis of biochemical parameters of various cyclophilins.

open access: yes, 2015
Comparative analysis of biochemical parameters of various cyclophilins.
Sanjay Kapoor (43319)   +10 more
core   +1 more source

Cyclophilin Succumbs to a Macrocyclic Chameleon [PDF]

open access: yesJournal of Medicinal Chemistry, 2018
Targets that have large and groove-shaped binding sites, such as cyclophilin, are difficult to drug with small molecules. Macrocycles of natural product origin can be ideal starting points for such targets as illustrated by the transformation of sanglifehrin A into an orally bioavailable potential candidate drug.
Bradley C. Doak, Jan Kihlberg
openaire   +2 more sources

Roles of Prolyl Isomerases in RNA-Mediated Gene Expression

open access: yesBiomolecules, 2015
The peptidyl-prolyl cis-trans isomerases (PPIases) that include immunophilins (cyclophilins and FKBPs) and parvulins (Pin1, Par14, Par17) participate in cell signaling, transcription, pre-mRNA processing and mRNA decay.
Roopa Thapar
doaj   +1 more source

Cyclophilins A, B, and C Role in Human T Lymphocytes Upon Inflammatory Conditions

open access: yesFrontiers in Immunology, 2021
Cyclophilins (Cyps) are a group of peptidyl-prolyl cis/trans isomerases that play crucial roles in regulatory mechanisms of cellular physiology and pathology in several inflammatory conditions.
Sandra Gegunde   +8 more
doaj   +1 more source

Nanomaterial‐based immune therapeutic strategies in neurodegenerative diseases

open access: yesBMEMat, EarlyView.
This review highlights the immunomodulatory potential of nanomaterials (NMs) in treating neurodegenerative diseases (NDs). It focuses on their roles in regulating innate and adaptive immune responses to maintain immune homeostasis. By providing insights into these mechanisms, the review lays the groundwork for innovative NMs therapeutic strategies to ...
Xinru Zhou   +6 more
wiley   +1 more source

S-cyclophilin. New member of the cyclophilin family associated with the secretory pathway

open access: yesJournal of Biological Chemistry, 1991
Cyclophilin is an abundant and ubiquitous cytosolic protein that is conserved throughout evolution from man to bacteria. It is the target of the immunosuppressive drug cyclosporin A. Cyclophilin has peptidyl-prolyl cis/trans-isomerase activity, and it accelerates protein folding in vitro, suggesting that it might be involved in the folding of cytosolic
P, Caroni   +3 more
openaire   +2 more sources

PDCD5 Contributes to Airway Epithelial Cell Damage via Mitochondrial Pathway and Participates in COPD Pathogenesis

open access: yesThe Kaohsiung Journal of Medical Sciences, EarlyView.
ABSTRACT Airway epithelial injury plays a critical role in the pathogenesis of chronic obstructive pulmonary disease (COPD). Mitochondrial dysfunction is implicated in this injury, while the underlying mechanism remains incompletely understood. RNA sequencing was conducted to identify key genes involved in mitochondrial dysfunction in airway epithelial
Hu Shan   +9 more
wiley   +1 more source

Cyclophilins and gibberellin-regulated proteins in IgE-mediated allergic diseases

open access: yes, 2023
International audienceThe prevalence of immunoglobulin E (IgE)-mediated allergic diseases is currently experiencing an epidemic trend characterized by an increase in both the number of affected individuals and the proportion of patients with multiple ...
Sénéchal, Hélène   +9 more
core   +1 more source

Home - About - Disclaimer - Privacy